Skip to main content

Takhzyro Prices, Coupons and Patient Assistance Programs

Takhzyro (lanadelumab) is a member of the hereditary angioedema agents drug class and is commonly used for Hereditary Angioedema.

Takhzyro Prices

The cost for Takhzyro subcutaneous solution (300 mg/2 mL) is around $25,404 for a supply of 2 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Takhzyro price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Subcutaneous Solution

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Takhzyro Coupons and Rebates

Takhzyro offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Takhzyro OnePath Co-Pay Assistance Program: Eligible commercially insured patients may save up to 100% off co-pay expenses up to the program maxium; for additional information contact the program at 866-888-0660.

Applies to:
Takhzyro
Number of uses:
Per prescription until program expires

Form more information phone: 866-888-0660 or Visit website

Patient Assistance Programs for Takhzyro

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Takhzyro (lanadelumab) Injection; Subcutaneous

More information please phone: 866-316-7263 Visit Website